How A CRO Exceeded Patient Enrollment Targets With AutoCruitment's Direct-To-Patient Strategy

When 85% of clinical trials face enrollment delays, the ripple effect on budgets and patient access to therapy is staggering. In the highly competitive landscape of Type 1 Diabetes research, relying solely on traditional site databases often leads to a recruitment standstill. This deep dive into a successful rescue mission reveals how shifting to a direct-to-patient digital strategy can turn a failing timeline into a success story.

By integrating sophisticated online screeners with EMR intelligence, researchers bypassed traditional bottlenecks and boosted enrollment rates. These methods didn’t just meet the target; they allowed screening to close two weeks early and shaved over a month off the total study duration. If your recruitment efforts are stalling against the limits of physician referrals and site-based reach, exploring these data-driven outreach and site-support tactics is essential. Open the full case study to see how digital precision and hands-on engagement can safeguard your next study timeline and bring life-changing therapies to market faster.